Patents by Inventor Christian Vandecasserie

Christian Vandecasserie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acellular pertussis vaccine with diphthriae- and tetanus-toxoids
    Publication number: 20040208898
    Abstract: The invention provides a diphtheria, tetanus and pertussis vaccine comprising a low dose of each of diphtheria toxoid (D), tetanus toxoid (T), pertussis toxin (PT), filamentous haemagglutinin (FHA) and pertactin (69K). The vaccine maintains an ability to prevent pertussis while showing exceptionally low reactogenicity. Combination vaccines comprising additional antigens are also provided.
    Type: Application
    Filed: May 4, 2004
    Publication date: October 21, 2004
    Applicant: SmithKline Beecham Biologicals S.A.
    Inventors: Patrick Florent, Jean Stephenne, Christian Vandecasserie
  • System for providing communication between the interior and the exterior of a compartment
    Publication number: 20040020129
    Abstract: A system for making a connection between the interior and exterior of a compartment, comprising a door opening through the compartment wall, a connector body which can engage with the wall, and having a connection port through it, and a removable cover on the connector body. The body is engaged with the door opening, and an inner door within the compartment engages and removes the cover. A preferred construction creates a single line of confidence seal. The system is particularly suited for sterile compartments.
    Type: Application
    Filed: July 25, 2003
    Publication date: February 5, 2004
    Inventors: Jacques Thilly, Christian Vandecasserie
  • Teat nozzle for dosing device with connection means
    Patent number: 6684918
    Abstract: A teat nozzle suitable for pediatric oral dosing of a fluid medicament comprising a tubular conduit which is engageable with a socket, and has at least one engagement part which can engage with an internal thread in the socket. The teat nozzle facilitates connection between the conduit and the socket. Dosing devices such as syringes and squeezable capsules provided with the nozzle, and a connection means for a vial having such a socket, are also described.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: February 3, 2004
    Assignee: SmithKline Beecham Biologicals s.a.
    Inventors: Jacques Thilly, Christian Vandecasserie
  • Acellular pertussis vaccine with diphthriae-and tetanus-toxoids
    Publication number: 20010014331
    Abstract: This invention relates to a diphtheria, tetanus and pertussis vaccine comprising a low dose of each of diphtheria toxoid (D), tetanus toxoid (T), pertussis toxin (PT), filamentous haemagglutinin (FHA) and pertactin (69K). The vaccine maintains an ability to prevent pertussis while showing exceptionally low reactogenicity. Combination vaccines comprising additional antigens are also provided.
    Type: Application
    Filed: April 6, 2001
    Publication date: August 16, 2001
    Applicant: SmithKline Beecham Biologicals s.a.
    Inventors: Patrick Florent, Jean Stephenne, Christian Vandecasserie
  • Vial
    Patent number: D485365
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: January 13, 2004
    Assignees: Medical Instill Technologies, Inc., GlaxoSmithKline Biologicals s.a.
    Inventors: Daniel Py, Norbert M. Assion, Julian V. Chan, Jacques Thilly, Christian Vandecasserie